XIAOLONG WANG

Dr. XIAOLONG WANG

Temple University, Philadelphia, Pennsylvania, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in International Journal of Biological Sciences
Verified
Journal Article
Open access
LYLushun Yuan
Lushun Yuan
GZGuang Zeng
Guang Zeng
LCLiang Chen
Liang Chen
GWGang Wang
Gang Wang
XIAOLONG WANGXIAOLONG WANG
XIAOLONG WANG
XWXinghuan Wang
Xinghuan Wang
Human clear cell renal cell carcinoma (ccRCC) is the most common solid lesion within kidney, and its prognostic is influenced by the progression covering a complex network of gene interactions. In our study, we screened differential expressed genes, and constructed protein-protein interaction (PPI) network and a weighted gene co-expression network to identify key genes and pathways associated with the progression of ccRCC (n = 56). Functional and pathway enrichment analysis demonstrated that upregulated differentially expressed genes (DEGs) were significantly enriched in response to wounding, positive regulation of immune system process, leukocyte activation, immune response and cell activation. Downregulated DEGs were significantly enriched in oxidation reduction, monovalent inorganic cation transport, ion transport, excretion and anion transport. In the PPI network, top 10 hub genes were identified (TOP2A, MYC, ALB, CDK1, VEGFA, MMP9, PTPRC, CASR, EGFR and PTGS2). In co-expression network, 6 ccRCC-related modules were identified. They were associated with immune response, metabolic process, cell cycle regulation, angiogenesis and ion transport. In conclusion, our study illustrated the hub genes and pathways involved in the progress of ccRCC, and further molecular biological experiments are needed to confirm the function of the candidate biomarkers in human ccRCC.

12 October 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MLMengxin Lu
Mengxin Lu
QGQiangqiang Ge
Qiangqiang Ge
GWGang Wang
Gang Wang
YLYongwen Luo
Yongwen Luo
XIAOLONG WANGXIAOLONG WANG
XIAOLONG WANG
XWXinghuan Wang
Xinghuan Wang
Cold-inducible RNA binding protein (CIRBP) has been reported to be associated with distinct tumorigenesis. In this study, we investigated the role of CIRBP in human bladder cancer (BCa), indicating that CIRBP is overexpressed in BCa tissues and cell lines to promote proliferation and migration. Moreover, CIRBP could induce expression of HIF-1α via binding to the 3′-UTR of its mRNA to increase the mRNA stability in BCa cells. Furthermore, we demonstrated that PTGIS is a HIF-1α targeted gene, a major regulator in hypoxic cancer progression by activating transcription of various oncogenes. Our results also suggested that overexpression of HIF-1α may suppress the expression of PTGIS in BCa cells, by binding to HRE sequence at the promoter region of PTGIS. In addition, we found a strongly downregulation of PTGIS in BCa tissue and transcriptionally inhibited by HIF-1α in BCa cells, which could be triggered by its DNA methylation. Further result suggested that knockdown of CIRBP could promote the expression of PTGIS, meanwhile knockdown of PTGIS could partially rescue CIRBP-deficiency induced inhibition of migration and proliferation in BCa cells. Taken together, our study indicated that CIRBP could be a novel oncogene in human bladder cancer inducing transcription of HIF-1α, which could inhibit expression of methylated PTGIS.

25 March 2018 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
QYQingfeng Yu
Qingfeng Yu
CGChristian Gratzke
Christian Gratzke
YWYiming Wang
Yiming Wang
AHAnnika Herlemann
Annika Herlemann
CSChristian Maximilian Sterr
Christian Maximilian Sterr
MHMartin Hennenberg
Martin Hennenberg

1 November 2016 in Medicine
Verified
Journal Article
Open access
CYCheng Yuan
Cheng Yuan
XXXin-Hua Xu
Xin-Hua Xu
XIAOLONG WANGXIAOLONG WANG
XIAOLONG WANG
LXLu Xu
Lu Xu
ZCZhuo Chen
Zhuo Chen
YLYuan-Qiang Li
Yuan-Qiang Li
The aim of this study was to investigate the role of uric acid (UA) in assessing rectal cancer metastasis. There were 475 newly diagnosed patients with complete data in our study, a total of 475 cases were reviewed, and divided into patients with metastasis and without metastasis. There were several statistical differences in age, tumor diameter, carcino-embryonic antigen (CEA), and C-reactive protein (CRP) between the 2 groups. Importantly, serum concentrations of UA in patients with lymphatic metastasis were found to be increased compared with patients without lymphatic metastasis (270.9 ± 52.99 vs 215.8 ± 43.55; P < 0.001). There were positive correlations of serum UA with creatinine (Cr), CRP, and CEA (r = 0.281, P = 0.023; r = 0.312, P = 0.001; r = 0.294, P = 0.017) in rectal cancer patients with metastasis. Multivariate analysis model revealed that elevated serum levels of UA were significant prognostic marker for lymphatic metastasis in patients with rectal cancer, independently of CRP, CEA, and tumor diameter (odds ratio 1.035, 95% CI 1.013–1.057, P = 0.002). In receiver-operating characteristic curve analysis, the area under the curve of serum UA in assessing metastatic rectal cancer patients was 0.803, with sensitivity of 0.864 and specificity of 0.739. Our results suggest that serum UA may be a novel marker in assessing tumor metastasis in patients with rectal cancer.

1 July 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
QYQingfeng Yu
Qingfeng Yu
CWChengjie Wu
Chengjie Wu
YCYeda Chen
Yeda Chen
BLBingsheng Li
Bingsheng Li
RWRuixiao Wang
Ruixiao Wang
GZGuohua Zeng
Guohua Zeng
Overactive bladder (OAB) is the most bothersome symptom in lower urinary tract symptoms (LUTS). Current pharmacologic treatment aims to inhibit detrusor contraction; however, shows unsatisfied efficacy and high discontinuation rate. LIM kinases (LIMKs) promote smooth muscle contraction in the prostate; however, their function in the bladder smooth muscle remains unclear. Here, we studied effects of the LIMK inhibitors on bladder smooth muscle contraction and proliferation both in vitro and in vivo experiments. Bladder expressions of LIMKs are elevated in OAB rat detrusor tissues. Two LIMK inhibitors, SR7826 and LIMKi3, inhibit contraction of human detrusor strip, and cause actin filament breakdown, as well as cell proliferation reduction in cultured human bladder smooth muscle cells (HBSMCs), paralleled by reduced cofilin phosphorylation. Silencing of LIMK1 and LIMK2 in HBSMCs resulted in breakdown of actin filaments and decreased cell proliferation. Treatment with SR7826 or LIMKi3 decreased micturition frequency and bladder detrusor hypertrophy in rats with bladder outlet obstruction. Our study suggests that LIMKs may promote contraction and proliferation in the bladder smooth muscle, which could be inhibited by small molecule LIMK inhibitors. LIMK inhibitors could be a potential therapeutic strategy for OAB- related LUTS.

1 April 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XIAOLONG WANGXIAOLONG WANG
XIAOLONG WANG
BLBingsheng Li
Bingsheng Li
ACAnna Ciotkowska
Anna Ciotkowska
BRBeata Rutz
Beata Rutz
MEMark G. Erlander
Mark G. Erlander
MHMartin Hennenberg
Martin Hennenberg